asimov.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $241.8MM
Asimov is a biotech company that specializes in research and development of gene therapies. In addition to the therapies it researches, Asimov provides a technology platform that scientists and geneticists can utilize to research prospective genetic treatments. The private company’s platform contains a genetic informational library and design software for simulation of synthetic biological processes.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
01/05/2023 | Series B-1 | $25MM | $xx.xx | $1.24B | Andreessen Horowitz, Casdin Capital, Cpp Investments, Fidelity, Horizons Ventures, Kdt, Pillar | |
Price per Share
$xx.xx
Shares Outstanding
269,743
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Casdin Capital, Cpp Investments, Fidelity, Horizons Ventures, Kdt, Pillar
|
||||||
01/05/2023 | Series B | $175MM | $xx.xx | $1.24B | Andreessen Horowitz, Casdin Capital, Cpp Investments, Fidelity, Horizons Ventures, Kdt, Pillar | |
Price per Share
$xx.xx
Shares Outstanding
1,888,204
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Casdin Capital, Cpp Investments, Fidelity, Horizons Ventures, Kdt, Pillar
|
||||||
06/30/2020 | Series A-1 | $12.1MM | $xx.xx | $134.95MM | Horizons Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,081,816
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Horizons Ventures
|
||||||
06/30/2020 | Series A | $25MM | $xx.xx | $134.95MM | Horizons Ventures, Wing Venture Capital | |
Price per Share
$xx.xx
Shares Outstanding
2,235,158
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Horizons Ventures, Wing Venture Capital
|
||||||
05/15/2017 | Series Seed | $4.7MM | $xx.xx | $15.67MM | Andreessen Horowitz | |
Price per Share
$xx.xx
Shares Outstanding
2,112,358
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz
|